{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:51:15Z","timestamp":1789696275563,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Resources in kind from EAFIT University, the University of Antioquia, and the Cooperative University of Colombia"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12889-018-5060-2","type":"journal-article","created":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T07:08:35Z","timestamp":1517209715000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia"],"prefix":"10.1186","volume":"18","author":[{"given":"Jaiberth Antonio","family":"Cardona-Arias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"L\u00f3pez-Carvajal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mery Patricia","family":"Tamayo-Plata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n Dar\u00edo","family":"V\u00e9lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,29]]},"reference":[{"key":"5060_CR1","volume-title":"Burden of disease in Colombia","author":"N Acosta","year":"2008","unstructured":"Acosta N, Pe\u00f1aloza R, Rodr\u00edguez J. Carga de la enfermedad en Colombia. In: Burden of disease in Colombia. Bogot\u00e1: Pontificia Universidad Javeriana; 2008."},{"issue":"5","key":"5060_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"J Alvar","year":"2012","unstructured":"Alvar J, V\u00e9lez I, Bern C, Herrero M, Desjeux P, Cano J, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012;7(5):1\u201312.","journal-title":"PLoS One"},{"issue":"3","key":"5060_CR3","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.vaccine.2012.11.032","volume":"31","author":"KM Bacon","year":"2013","unstructured":"Bacon KM, Hotez PJ, Kruchten SD, Kamhawi S, Bottazzi ME, Valenzuela JG, et al. The potential economic value of a cutaneous leishmaniasis vaccine in seven endemic countries in the Americas. Vaccine. 2013;31(3):480\u20136.","journal-title":"Vaccine"},{"key":"5060_CR4","doi-asserted-by":"publisher","unstructured":"Cardona J, L\u00f3pez L, V\u00e9lez I. Efficacy of thermotherapy to treat cutaneous leishmaniasis: a meta-analysis of controlled clinical trials. Plos One Clinical trial. 2015; \n                    https:\/\/doi.org\/10.1371\/journal.pone.0122569\n                    \n                  .","DOI":"10.1371\/journal.pone.0122569"},{"issue":"2","key":"5060_CR5","first-page":"129","volume":"39","author":"JP Dedet","year":"1991","unstructured":"Dedet JP, Pillot B, Gentilini M. Evaluation of the socioeconomic costs of cutaneous leishmaniasis in French Guiana. Rev Epidemiol Sante Publique. 1991;39(2):129\u201333.","journal-title":"Rev Epidemiol Sante Publique"},{"issue":"2","key":"5060_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s40257-015-0114-z","volume":"16","author":"HJ de Vries","year":"2015","unstructured":"de Vries HJ, Reedijk SH, Schallig HD. Cutaneous leishmaniasis: recent developments in diagnosis and management. Am J Clin Dermatol. 2015;16(2):99\u2013109.","journal-title":"Am J Clin Dermatol"},{"issue":"Suppl 1","key":"5060_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1590\/0037-8682-0268-2013","volume":"48","author":"JA Guerra","year":"2015","unstructured":"Guerra JA, Maciel MG, Guerra MV, Talhari AC, Prestes SR, Fernandes MA, et al. Tegumentary leishmaniasis in the state of Amazonas: what have we learned and what do we need? Rev Soc Bras Med Trop. 2015;48(Suppl 1):12\u20139.","journal-title":"Rev Soc Bras Med Trop"},{"key":"5060_CR8","volume-title":"Vigilancia Rutinaria. [Routine surveillance]","author":"Instituto Nacional de Salud de Colombia, Sistema Nacional de Vigilancia en Salud P\u00fablica \u2013SIVIGILA. [National Institute of Health of Colombia, National Public Health Surveillance System -SIVIGILA]","year":"2016","unstructured":"Instituto Nacional de Salud de Colombia, Sistema Nacional de Vigilancia en Salud P\u00fablica \u2013SIVIGILA. [National Institute of Health of Colombia, National Public Health Surveillance System -SIVIGILA]. Vigilancia Rutinaria. [Routine surveillance]. Bogot\u00e1: Instituto Nacional de Salud de Colombia; 2016."},{"issue":"3","key":"5060_CR9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1590\/S0036-46652013000300011","volume":"55","author":"L L\u00f3pez","year":"2013","unstructured":"L\u00f3pez L, Cruz C, Godoy G, Robledo S, V\u00e9lez I. Thermotherapy effective and safer than miltefosine in the treatment of cutaneous leishmaniasis in Colombia. Rev Inst Med Trop Sao Paulo. 2013;55(3):197\u2013204.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"5060_CR10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1745-6215-13-58","volume":"13","author":"L L\u00f3pez","year":"2012","unstructured":"L\u00f3pez L, Robayo M, Vargas M, V\u00e9lez I. Thermotherapy. An alternative for the treatment of American cutaneous leishmaniasis. Trials. 2012;13:58.","journal-title":"Trials"},{"issue":"2","key":"5060_CR11","doi-asserted-by":"publisher","first-page":"e0003527","DOI":"10.1371\/journal.pntd.0003527","volume":"10","author":"DS Marinho","year":"2015","unstructured":"Marinho DS, Casas CN, Pereira CC, Leite IC. Health economic evaluations of visceral leishmaniasis treatments: a systematic review. PLoS Negl Trop Dis. 2015;10(2):e0003527.","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"5060_CR12","doi-asserted-by":"publisher","first-page":"226","DOI":"10.15446\/rsap.v18n2.31692","volume":"18","author":"O Martinez","year":"2015","unstructured":"Martinez O, Quintero P, Mayor L. Estimaci\u00f3n de a\u00f1os de vida ajustados por discapacidad seg\u00fan subtipo de ataque cerebrovascular isqu\u00e9mico agudo. [Estimated disability-adjusted life years according to subtype of acute ischemic stroke.] Rev. Salud P\u00fablica. 2015;18(2):226\u201337.","journal-title":"Salud P\u00fablica"},{"issue":"2","key":"5060_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3315\/jdcr.2013.1135","volume":"7","author":"A Masmoudi","year":"2013","unstructured":"Masmoudi A, Hariz W, Marrekchi S, Amouri M, Turki H. Old world cutaneous leishmaniasis: diagnosis and treatment. J Dermatol Case Rep. 2013;7(2):31\u201341.","journal-title":"J Dermatol Case Rep"},{"key":"5060_CR14","first-page":"1","volume-title":"The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020","author":"CJL Murray","year":"1996","unstructured":"Murray CJL, Lopez AD. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Boston: Harvard School of Public Health; 1996. p. 1\u201398."},{"key":"5060_CR15","unstructured":"Ni\u00f1o CP. (2014). An\u00e1lisis de costo-efectividad de los tratamientos incluidos en la gu\u00eda de atenci\u00f3n integral del Ministerio de Protecci\u00f3n social de 2010 en pacientes adultos con leishmaniasis cut\u00e1nea y muco-cut\u00e1nea en Colombia. [cost-effectiveness analysis of the treatments included in the comprehensive care guide of the Ministry of Social Protection 2010 in adult patients with cutaneous and muco-cutaneous leishmaniasis in Colombia.] Bogot\u00e1: Universidad Nacional de Colombia."},{"issue":"3","key":"5060_CR16","doi-asserted-by":"publisher","first-page":"e2130","DOI":"10.1371\/journal.pntd.0002130","volume":"7","author":"P Olliaro","year":"2013","unstructured":"Olliaro P, Vaillant M, Arana B, Grogl M, Modabber F, Magill A, et al. Methodology of clinical trials aimed at assessing interventions for Cutaneous Leishmaniasis. PLoS Negl Trop Dis. 2013;7(3):e2130.","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"5060_CR17","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1590\/0102-311X00172512","volume":"29","author":"PW Orellano","year":"2013","unstructured":"Orellano PW, Vazquez N, Salomon OD. Cost-effectiveness of prevention strategies for American tegumentary leishmaniasis in Argentina. Cad Saude Publica. 2013;29(12):2459\u201372.","journal-title":"Cad Saude Publica"},{"key":"5060_CR18","volume-title":"Leishmaniasis en las Am\u00e9ricas: Recomendaciones para el tratamiento. [Leishmaniasis in the Americas: recommendations for treatment]","author":"OPS Organizaci\u00f3n Panamericana de la Salud. [PAHO Pan American Health Organization]","year":"2013","unstructured":"OPS Organizaci\u00f3n Panamericana de la Salud. [PAHO Pan American Health Organization]. Leishmaniasis en las Am\u00e9ricas: Recomendaciones para el tratamiento. [Leishmaniasis in the Americas: recommendations for treatment]. Washington: PAHO; 2013."},{"key":"5060_CR19","volume-title":"Estimaci\u00f3n de la carga de la enfermedad para Colombia, 2010. [Estimation of disease burden for Colombia, 2010]","author":"RE Pe\u00f1aloza","year":"2014","unstructured":"Pe\u00f1aloza RE, Salamanca N, Rodriguez JM, Rodriguez J, Beltr\u00e1n AR. Estimaci\u00f3n de la carga de la enfermedad para Colombia, 2010. [Estimation of disease burden for Colombia, 2010]. Bogot\u00e1: Pontificia Universidad Javeriana; 2014."},{"key":"5060_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2334-7-3","volume":"7","author":"R Reithinger","year":"2007","unstructured":"Reithinger R, Coleman PG. Treating cutaneous leishmaniasis patients in Kabul, Afghanistan: cost-effectiveness of an operational program in a complex emergency setting. BMC Infect Dis. 2007;7:3.","journal-title":"BMC Infect Dis"},{"key":"5060_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/538629","volume":"2013","author":"M Ruoti","year":"2013","unstructured":"Ruoti M, Oddone R, Lampert N, Oru\u00e9 E, Miles MA, Alexander N, et al. Mucocutaneous leishmaniasis: knowledge, attitudes, and practices among paraguayan communities, patients, and health professionals. J Trop Med. 2013;2013:1\u201310.","journal-title":"J Trop Med"},{"issue":"3","key":"5060_CR22","doi-asserted-by":"publisher","first-page":"345","DOI":"10.7205\/MILMED-D-11-00161","volume":"177","author":"N Safi","year":"2012","unstructured":"Safi N, Davis GD, Nadir M, Hamid H, Robert LL Jr, Case AJ. Evaluation of thermotherapy for the treatment of Cutaneous Leishmaniasis in Kabul, Afghanistan: a randomized controlled trial. Mil Med. 2012;177(3):345\u201351.","journal-title":"Mil Med"},{"key":"5060_CR23","volume-title":"WHO guide to cost-effectiveness analysis","author":"T Tan-Torres Edejer","year":"2003","unstructured":"Tan-Torres Edejer T, Baltussen R, Adam T, Hutubessy R, Acharya A, Evans DB, Murray CJL. WHO guide to cost-effectiveness analysis. Geneva: World Health Organization, WHO; 2003."},{"key":"5060_CR24","doi-asserted-by":"publisher","unstructured":"Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. SeminRadiat Oncol. 2003;(3, 3):176\u201381. \n                    https:\/\/doi.org\/10.1016\/S1053-4296(03)00031-6\n                    \n                  .","DOI":"10.1016\/S1053-4296(03)00031-6"},{"issue":"2","key":"5060_CR25","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1365-3156.2006.01782.x","volume":"2","author":"V Vanlerberghe","year":"2007","unstructured":"Vanlerberghe V, Diap G, Guerin P, Meheus F, Gerstl S, Van der Stuyft P, et al. Drug policy for visceral leishmaniasis: a cost-effectiveness analysis. Trop Med Int Health. 2007;2(2):274\u201383.","journal-title":"Trop Med Int Health"},{"issue":"12","key":"5060_CR26","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1111\/j.1365-3156.2007.01962.x","volume":"12","author":"JC Vega","year":"2007","unstructured":"Vega JC, S\u00e1nchez BF, Montero LM, Monta\u00f1a R, Del Pilar MM, Due\u00f1es B, et al. Short communication: the cost-effectiveness of cutaneous leishmaniasis patient management during an epidemic in chaparral, Colombia in 2004. Tropical Med Int Health. 2007;12(12):1540\u20134.","journal-title":"Tropical Med Int Health"},{"key":"5060_CR27","unstructured":"Von Stebut E. (2015). Leishmaniasis. J Dtsch Dermatol Ges. Mar;13(3):191-200."},{"key":"5060_CR28","volume-title":"Global health estimates 2014 summary tables: DALY by cause, age and sex, by WHO region, 2000\u20132012","author":"WHO World Health Organization","year":"2014","unstructured":"WHO World Health Organization. Global health estimates 2014 summary tables: DALY by cause, age and sex, by WHO region, 2000\u20132012. Geneva: WHO; 2014."},{"key":"5060_CR29","volume-title":"Disease burden. Estimates for 2000\u20132012","author":"WHO World Health Organization","year":"2016","unstructured":"WHO World Health Organization. Disease burden. Estimates for 2000\u20132012. Geneva: WHO; 2016."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-018-5060-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T19:06:11Z","timestamp":1548702371000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-018-5060-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,29]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["5060"],"URL":"https:\/\/doi.org\/10.1186\/s12889-018-5060-2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732585217.793580931","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,29]]},"assertion":[{"value":"1 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JACA is Microbiologist, MSc in Epidemiology, MSc in Applied Economics. LLC is Bacteriologist, MSc PhD in EpidemiologyMPTP is Economist, MSc in Applied Economics, PhD in Economics. IDV is MD MSc PhD.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"185"}}